|
⚲
|
| Keyboard |
| Squadron Capital LLC
✚
|
|
|---|---|
| CIK # | 0002050709, 0001719228 |
| CIK | Period |
|---|---|
| 0002050709 0001719228 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Camp Nine Inc | 59.0 | ||
| UNUM Therapeutics Inc | 30.3 | ||
| Kodiak Sciences Inc | 14.5 | ||
| Abivax Sa | 14.5 | ||
| Edgewise Therapeutics Inc | 11.0 | ||
| Zentalis Pharmaceuticals Inc | 9.4 | ||
| Nektar Therapeutics | 9.0 | ||
| Adlai Nortye Ltd | 8.8 | ||
| Relay Therapeutics Inc | 8.2 | ||
| MAZE Therapeutics Inc | 7.7 | ||
| IDEAYA Biosciences Inc | 7.5 | ||
| Scynexis Inc | 7.0 | ||
| C4 Therapeutics Inc | 5.9 | ||
| Inhibikase Therapeutics Inc | 5.9 | ||
| Neuralstem Inc | 5.2 | ||
| Eupraxia Pharmaceuticals Inc | 4.9 | ||
| GH Research PLC | 4.6 | ||
| Karyopharm Therapeutics Inc | 4.2 | ||
| Promis Neurosciences Inc | 4.1 | ||
| Marathon Bar Corp | 3.6 | ||
| Inventiva Sa | 3.0 | ||
| ALX Oncology Holdings Inc | 2.9 | ||
| Context Therapeutics Inc | 2.9 | ||
| NextCure Inc | 2.8 | ||
| Arrivent Biopharma Inc | 2.5 | ||
| Sol-Gel Technologies Ltd | 2.5 | ||
| Pasithea Therapeutics Corp | 1.6 | ||
| Onconova Therapeutics Inc | 0.9 | ||
| AMHN Inc | 0.8 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001719228] | |
| 4 | [0001719228] | |
| 5 | [0001719228] | |
| SC 13D | [0001719228] | |
| SC 13G | [0001719228] | |
| 13F-HR | [0002050709] | |
| SC 13G | [0002050709] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Squadron Capital LLC | |
| Alphatec Holdings Inc | |
| Orthopediatrics Corp | |
| Squadron Capital Holdings LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alphatec Holdings Inc ATEC
Common Stock
|
2025-12-09 | Sell | 28,834 | $21.03 | 606,379 |
|
Alphatec Holdings Inc ATEC
Common Stock
|
2025-12-08 | Sell | 221,166 | $21.20 | 4,688,719 |
|
Alphatec Holdings Inc ATEC
Common Stock
|
2025-11-24 | Sell | 250,000 | $20.62 | 5,155,000 |
|
Alphatec Holdings Inc ATEC
Common Stock
|
2025-11-12 | Sell | 250,000 | $20.80 | 5,200,000 |
|
Orthopediatrics Corp KIDS
Common Stock
|
2022-09-20 | Option exercise | 1,525,000 | $0.00 | |
|
Orthopediatrics Corp KIDS
Warrants (right to buy) · derivative
|
2022-09-20 | Option exercise | 1,525,000 | $0.00 | |
|
Orthopediatrics Corp KIDS
Warrants (right to buy) · derivative
|
2022-08-11 | Buy | 1,525,000 | $55.00 | 83,875,000 |
|
Orthopediatrics Corp KIDS
Common Stock
|
2020-06-19 | Option exercise | 1,340 | $30.97 | 41,500 |
|
Orthopediatrics Corp KIDS
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Option exercise | 1,340 | $30.97 | 41,500 |
|
Orthopediatrics Corp KIDS
Series A Convertible Preferred Stock · derivative
|
2017-10-16 | Conversion | 1,000,000 | $0.00 | |
|
Orthopediatrics Corp KIDS
Series B Convertible Preferred Stock · derivative
|
2017-10-16 | Conversion | 4,157,960 | $0.00 | |
|
Orthopediatrics Corp KIDS
Common Stock
|
2017-10-16 | Conversion | 3,455,833 | ||
|
Orthopediatrics Corp KIDS
Common Stock
|
2017-10-16 | Conversion | 1,920,062 |